Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Stem Cells (Dayton, Ohio)|May 28, 2010
An inducible caspase 9 suicide gene to improve the safety of mesenchymal stromal cell therapiesCarlos Almeida Ramos, Zahra Asgari, Enli Liu, et al.
Blood|November 13, 2004
Molecular transfer of CD40 and OX40 ligands to leukemic human B cells induces expansion of autologous tumor-reactive cytotoxic T lymphocytesEttore Biagi, Gianpietro Dotti, Eric Yvon, et al.
Blood|February 17, 2005
Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosisGianpietro Dotti, Barbara Savoldo, Martin Pule, et al.
Journal of Virology|September 27, 2003
Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytesStéphane Vigouroux, Eric Yvon, Hans-Joachim Wagner, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2011
Combining mTor inhibitors with rapamycin-resistant T cells: a two-pronged approach to tumor eliminationLeslie E Huye, Yozo Nakazawa, Mayuri P Patel, et al.
Human Gene Therapy|April 30, 2003
Bystander transfer of functional human CD40 ligand from gene-modified fibroblasts to B-chronic lymphocytic leukemia cellsEttore Biagi, Eric Yvon, Gianpietro Dotti, et al.
The Journal of Biological Chemistry|August 27, 2009
Tumor necrosis factor-alpha induces RelA degradation via ubiquitination at lysine 195 to prevent excessive nuclear factor-kappaB activationYihui Fan, Renfang Mao, Yanling Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2013
T lymphocytes redirected against the chondroitin sulfate proteoglycan-4 control the growth of multiple solid tumors both in vitro and in vivoClaudia Geldres, Barbara Savoldo, Valentina Hoyos, et al.
Cytotherapy|July 13, 2011
Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemiaFatma Visal Okur, Eric Yvon, Ettore Biagi, et al.
Blood|July 23, 2014
Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapyAndras Heczey, Daofeng Liu, Gengwen Tian, et al.
Pageof 4